ZNTL

Conviction 56HealthcareScan · Mon, Aug 10, 2026

ZNTL$4.14-1.90%

ResistanceSupportVol 14

Vol MA14 1.18M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Zentalis Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.zentalis.com ↗

Price4.14

Change-1.90%

Gap-1.18%

Rel volume2.91×

Avg volume1.29M

Avg $ vol6.02M

SMA 204.69

SMA 504.31

SMA 2003.03

Price vs 50-4.01%

Price vs 200+36.79%

MA stackmixed

50/200 cross—

Supertrendup · 3.97

RSI (14)41

MACD hist-0.07

MACD crossbear · 1d

Stoch %K / %D11 / 29

ADX (14)16

+DI / −DI18 / 29

RSI divergence—

MACD divergence—

ATR %+9.72%

ADR %8.52%

52w high6.61

52w low1.28

From 52w high-37.37%

Above 52w low+223.44%

New 52w highNo

SqueezeFired

Bollinger width22.97%

%B-0.01

Donchian pos8.28%

Donchian high5.58

Donchian low4.01

AVWAP (52w high)4.90

vs AVWAP high-15.43%

AVWAP (52w low)3.89

vs AVWAP low+6.54%

OBV trendFlat

Chaikin MF (20)-0.10

Today vs 20d2.91×

Avg vol (14d)1.18M

Avg vol (20d)1.29M

Avg $ vol (20d)6.02M

Market cap296.72M

RS 3m (vs SPY)-5.93%

RS 6m (vs SPY)+76.84%

RS line new highNo

Trend template5/8

Technical rank61.7

1 week-10.97%

1 month-15.16%

3 months-6.12%

6 months+73.22%

1 year+185.52%

YTD+202.19%

P/E-2.16

P/B2.07

P/S—

P/FCF-2.37

EPS-1.91

Div yield—

ROE-95.42%

ROA-63.65%

Debt/Eq—

Current4.82

EV/EBITDA-1.79

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth17.35%

Price target7.75

Target upside87.20%

Analyst ratingBuy

Institutional70.73%

Ent. value271.94M

Revenue0

Net income-42.29M

Gross profit—

Free cash flow-125.25M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out71.19M

Employees106

ListedFri, Apr 3, 2020

Free float46.67M

Float %64.6%

Short interest6.15M

Days to cover6.3d

Short volume67.4%

Squeeze score85 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.59 vs −$0.45

Last surprise-31.1% miss

Setup gradeC

Conviction56 / 100

Pattern quality—

Tech rank61.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.37

Support3.49

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ZNTL

All disclosures →

No recent disclosed trades by Congress in ZNTL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZNTL · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Johnson David Michael Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Myers Scott Dunseth Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Skvarka Jan Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Walker Luke Nathaniel Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Kariuki Enoch Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Campbell Shannon Director · Common Stock · 2026-05-26	Grant	114.2K	$0	2026-05-26	2026-05-27

SEC filings

EDGAR filings in ZNTL · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.